共 50 条
- [1] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma [J]. Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
- [2] Erratum: Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma [J]. Nature Clinical Practice Oncology, 2008, 5 : 493 - 493
- [3] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
- [5] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma (vol 5, pg 374, 2008) [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (08): : 493 - 493
- [6] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma [J]. International Journal of Hematology, 2010, 92 : 118 - 126
- [9] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone [J]. International Journal of Hematology, 2019, 109 : 79 - 90